AmbAgon Therapeutics
About:
AmbAgon Therapeutics is a developer of cancer molecule therapeutics.
Website: https://ambagontx.com/
Top Investors: Mission BioCapital, RA Capital Management, AbbVie, MRL Ventures Fund, Surveyor Capital
Description:
AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin.
Total Funding Amount:
$148M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2020-01-01
Founders:
Christian Ottmann, Lucas Brunsveld, Michelle Arkin
Number of Employees:
11-50
Last Funding Date:
2022-05-27
IPO Status:
Private
Industries:
© 2025 bioDAO.ai